Axon Enterprise scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting the company’s future cash flows and then discounting them back to today’s value. It is essentially asking what those future dollars are worth in today’s terms.
For Axon Enterprise, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $28.7m. Analyst estimates and subsequent extrapolations point to free cash flow of $1,001.2m in 2028, with additional projections running out to 2035, all expressed in $.
After discounting these projected cash flows, the model arrives at an estimated intrinsic value of about $386.24 per share. Compared with the recent share price around $447, the DCF output suggests the stock is priced about 15.9% above this intrinsic value, which indicates it screens as overvalued on this metric alone.
Result: OVERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Axon Enterprise may be overvalued by 15.9%. Discover 48 high quality undervalued stocks or create your own screener to find better value opportunities.
For profitable companies that are still heavily focused on scaling revenue, the P/S ratio can be a useful cross check because it compares what you pay for each dollar of sales, regardless of how accounting profits look in any single year.
In general, higher expected growth and lower perceived risk can justify a higher P/S ratio, while lower growth expectations or higher risk usually line up with a lower, more conservative multiple.
Axon Enterprise currently trades on a P/S of 12.09x. That is above the Aerospace & Defense industry average of 5.54x and also ahead of the peer group average of 6.79x, so on simple comparisons the stock screens as expensive.
Simply Wall St’s Fair Ratio is a proprietary estimate of what a reasonable P/S might be for Axon Enterprise, based on factors such as its growth profile, industry, profit margins, market value and risk characteristics. This makes it a more tailored yardstick than a broad industry or peer average, which do not adjust for these company specific traits.
On this framework, Axon Enterprise’s Fair Ratio is 15.44x, above the current 12.09x P/S. This indicates that on this metric the stock screens as undervalued.
Result: UNDERVALUED
Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.
Earlier it was mentioned that there is an even better way to think about valuation. On Simply Wall St that starts with Narratives, where you choose a clear story for Axon Enterprise, translate that story into assumptions for revenue, earnings and margins, and the platform turns it into a fair value you can compare with the current share price to help decide whether the stock looks attractively or richly priced.
A Narrative is simply your view of what Axon Enterprise really is, such as a hardware focused TASER business or a public safety software and data platform. It is linked directly to a forecast and a fair value number, instead of sitting separately from the financials.
On the Simply Wall St Community page, Narratives are set up so you can pick or adjust a storyline, see how that maps into things like revenue growth, profit margins, discount rates and P/E assumptions, and then instantly see the resulting fair value alongside the latest market price.
For Axon Enterprise, one investor might build a bullish Narrative with a fair value around US$925, based on strong recurring revenue and AI driven products. Another might prefer a more cautious Narrative closer to US$420. As new data, news or earnings arrive, these Narratives update automatically so you can see how your story and fair value change over time.
For Axon Enterprise, we will make it really easy for you with previews of two leading Axon Enterprise Narratives:
Fair value in this bullish Narrative: about US$662.04 per share.
At the recent price of about US$447.59, this Narrative implies the stock is around 32.4% below that fair value estimate.
Revenue growth assumption: 28.14% a year.
Fair value in this more cautious Narrative: about US$420.19 per share.
At the recent price of about US$447.59, this Narrative implies the stock is around 6.1% above that fair value estimate.
Revenue growth assumption: 26.73% a year.
These two Narratives bracket a wide range of potential outcomes around Axon Enterprise. The next step is to decide which story, or blend of stories, aligns more closely with how you see the business, its risks and the price you are willing to pay for that exposure.
Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English